UniXell Biotechnology

About:

UniXell Biotechnology is a new-generation cell therapy drug developer, focuses on the development of a new generation of cell therapy drugs.

Website: http://unixell.com/

Top Investors: Hillhouse Investment, Fosun Pharma, CDH Investments, TF Capital, Sherpa Healthcare Partners

Description:

Yuesai Biotechnology is a cell therapy drug developer that uses human pluripotent stem cell technology. Yuesai Biotechnology develops stem cell therapy for neurodegenerative diseases, rare diseases, and tumors using its proprietary intellectual property rights of human pluripotent stem cell preparation, cultivation, differentiation, and gene editing technology platform.